1. POSTER: MDS-1311: Survival and Toxicity Outcomes With Hypomethylating Agent Plus Venetoclax vs Hypomethylating Agent Alone in Higher-Risk Myelodysplastic Syndrome: A Propensity-Matched Retrospective Cohort Study
    Shankar Biswas et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
  2. POSTER: MPN-1283: Direct Oral Anticoagulants Versus Warfarin in Philadelphia-Negative Myeloproliferative Neoplasms With Atrial Fibrillation: A Propensity-Matched Retrospective Cohort Study
    Kumar Anmol et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
  3. POSTER: MDS-1271: Comparative Outcomes With Luspatercept Versus Erythropoiesis-Stimulating Agents in Lower-Risk Myelodysplastic Syndromes: A Propensity Score-Matched Retrospective Cohort Study
    Shankar Biswas et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
  4. POSTER: MDS-1298: Two-Year Outcomes of Iron Chelation Therapy in Transfusion-Exposed Patients With Myelodysplastic Syndromes: A Propensity Score–Matched TriNetX Analysis
    Kofi Boakye Opoku et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
  5. POSTER: AML-1755: Preventable Leukemia in the Workplace: Global Burden of Occupational Benzene-Attributable Leukemia, 1990–2023
    Hardik Jain et al. · Clinical Lymphoma Myeloma & Leukemia · 2026
  6. Real-time genomic characterization of pediatric acute leukemia using adaptive sampling
    Jeremy Wang et al. · UNC Libraries · 2026
  7. Statin use and severe, critical, or fatal outcomes among individuals with coronavirus disease 2019
    Adeel A. Butt et al. · IJID Regions · 2026
  8. Decoding Small Cell Lung Cancer: Molecular Subtypes, Surface Antigens, and the Target-Modality Problem
    Mijail I. Zambrano Iglesias et al. · Cancers · 2026
  9. Real-World Survival and Toxicity Outcomes of Fluorouracil With vs. Without Leucovorin in Metastatic Colorectal Cancer
    Bugra Zengin et al. · Journal of Gastrointestinal Cancer · 2026
  10. Lung Cancer Disparities in the United States: The Role of Smoking, Comorbidities, Socioeconomic Status, and Regional Variation
    Bugra Zengin et al. · Cureus · 2026